Tex. Health & Safety Code § 481.203 · Subchapter G. THERAPEUTIC RESEARCH PROGRAM
PATIENT PARTICIPATION.
Text — Current through the 89th 2nd Called Legislative Session, 2025
(a) A person may not be considered for participation as a recipient of tetrahydrocannabinols and their derivatives through a research program unless the person is recommended to a person in charge of an approved research program and the review board by a physician who is licensed by the Texas Medical Board and is attending the person.
(b) A physician may not recommend a person for the research program unless the person:
(1) has glaucoma or cancer;
(2) is not responding to conventional treatment for glaucoma or cancer or is experiencing severe side effects from treatment; and
(3) has symptoms or side effects from treatment that may be alleviated by medical use of tetrahydrocannabinols or their derivatives.
Notes and commentary — not statutory text
History
Acts 1989, 71st Leg., ch. 678, Sec. 1, eff. Sept. 1, 1989.
Amended by:
Acts 2015, 84th Leg., R.S., Ch. 1 (S.B. 219), Sec. 3.1234, eff. April 2, 2015.
Source of truth
- Edition
- Current through the 89th 2nd Called Legislative Session, 2025
- Official file
- https://statutes.capitol.texas.gov/Docs/HS/htm/HS.481.htm
- Text hash
- sha256 d6d23e2eca959a21af4fc623c726dbf9b79d5f8e1cbf06979278d1f2b3d1db20
- Composed by
- compose_tx.py 2026-10-05: the Legislative Council's chapter files read in document order; verify_tx.py's independent reading (lxml DOM walk) agrees character for character
Procedural information only. Not legal advice and not a substitute for the advice of an attorney. Confirm the current text with the official publisher before relying on it.